Bio-Rad Laboratories | BIO - Actif À Court Terme





Actif À Court Terme Changement Date
Abbott USD 25.51B 488M 2026-03
Agilent USD 4.76B 148M 2026-03
Becton, Dickinson and Co. USD 8.01B 1.18B 2026-03
Bio Techne USD 688.05M 50.62M 2026-03
Bio-Rad Laboratories USD 2.94B 35.9M 2026-03
Bruker USD 2.1B 108.9M 2026-03
Charles River Laboratories USD 1.49B 41.76M 2026-03
Danaher USD 13.94B 1.18B 2026-03
General Electric Aerospace USD 40.36B 235M 2026-03
Illumina USD 2.74B 551M 2026-03
IQVIA Holdings USD 6.22B 29M 2026-03
Laboratory Of America USD 4.56B 538.3M 2026-03
Merck USD 35.02B 8.5B 2026-03
Mettler Toledo International USD 1.33B 30.76M 2026-03
Myriad Genetics USD 312.8M 19.8M 2026-03
OraSure Technologies USD 240.78M 21.13M 2026-03
Pacific Biosciences Of California USD 369.52M 5.54M 2026-03
Quest Diagnostics USD 2.57B 188M 2026-03
Repligen USD 1.16B 23.98M 2026-03
Revvity USD 2.13B 111.43M 2026-03
Roche Holding CHF 38.73B 3.03B 2025-12
Siemens EUR 68.95B 1.04B 2026-03
Standard Biotools USD 521.45M 67.19M 2026-03
Thermo Fisher Scientific USD 22.32B 6.39B 2026-03
Tosoh JPY 798.07B 38.8B 2026-03
Waters USD 3.72B 1.73B 2026-03